Sep 2026
InvAscent, through its managed funds, will make an initial investment of up to INR 2,433 million in RPG Active Pharma Limited (“RPG Active Pharma” or “RPG AP”), a wholly owned subsidiary of RPG Life Sciences Limited. The dedicated API business, backed by focused capital and management attention, is expected to support capacity expansion, new product development and organic and inorganic growth opportunities.
RPG AP has also entered into an agreement to acquire Actis Generics Private Limited, a Visakhapatnam-based API manufacturer. The acquisition is expected to expand RPG AP’s manufacturing footprint and broaden its product portfolio.
RPG AP has further agreed to acquire the API and intermediates business of Raghava Life Sciences. The proposed transaction will add an EU-GMP-certified manufacturing facility near Hyderabad with approximately 300 KL of capacity and a portfolio of over 20 commercialised APIs. The acquisition is expected to enhance RPG AP’s manufacturing and regulatory capabilities while providing access to a broader portfolio of attractive products.
Together, RPG AP’s existing operations and the proposed acquisitions of Actis Generics and Raghava Life Sciences will create a larger and more diversified API business with expanded manufacturing capabilities and a broader product portfolio.
“Building a meaningful and scalable presence in APIs has been a strategic priority for RPG Life Sciences,” said Ashok Nair, Managing Director, RPG Life Sciences. He added that the partnership with InvAscent and the proposed acquisition of Actis Generics would support the creation of a larger API business with wider manufacturing capabilities and a broader product portfolio. He also noted that the Raghava transaction would further advance RPG AP’s strategy and create opportunities to improve commercialisation and operating leverage.
Jeevak Gupta, Managing Director, InvAscent, said that InvAscent sees significant long-term potential in high-quality API manufacturing and expects RPG AP to benefit from growing global demand and the continued diversification of pharmaceutical supply chains.
About InvAscent
Founded in 2005, InvAscent is a healthcare and life sciences-focused private equity firm and investment advisor to the India Life Sciences Funds. Its investments span pharmaceuticals, healthcare delivery, medical devices, animal health, nutraceuticals and healthtech. The team combines investment experience with deep sector expertise to support the growth of its portfolio companies.
For more information, please visit www.invascent.com.
About RPG Active Pharma
RPG Active Pharma is an API manufacturer headquartered in Mumbai, with a strong presence across Latin America and Southeast Asia and leadership positions in select niche APIs. The company is focused on building a scaled API business through capacity expansion, product development and strategic acquisitions.
RPG Active Pharma is a subsidiary of RPG Life Sciences, an integrated pharmaceutical company with over 30 years of experience across branded formulations, global generics and synthetic APIs.
For more information, please visit www.rpglifesciences.com.